Ken Riker is a skilled professional, that works in Celgene main office of which is in 493. on the position of Director since 2019. Ken gained professional experience in more than five positions at various companies. Ken Riker went to the University of Washington and got education from 1982 to 1995. Everett, Washington is the area, where this professional was known to settle. Ken's phone and email can be easily accessed through this website on demand.
Name variants:
Kendall Riker,
Kendrick Riker,
Kenneth Riker,
Kent Riker
Last updated May 31, 2024
Contact Information
Workplace
Director
Summit, NJ
Industry
Biotechnology, Sales Of Ethical Prescription Pharmaceuticals, Sales of Ethical Prescription Pharmaceuticals, Manufacturing, Chemical Manufacturing, Pharmaceutical and Medicine Manufacturing, Mfg Pharmaceutical Preparations, Pharmaceutical Research & Development, Pharmaceutical Preparations, Whol Drugs/Sundries, Internist
Colleagues
Work History
Education
1982 — 1995
Occupations
Executive
Director
Scientist
Biotechnology Professional
Operations Manager
Biologist
Biological Scientist
Skills
Biotechnology
Gmp
Biopharmaceuticals
Pharmaceutical Industry
Fda
Quality Control
Validation
Capa
Change Control
21 Cfr Part 11
FAQs about Ken Riker
What's the main profession of Ken Riker?
The expert is a Director.
What are the profession of The professional?
These person's professions are Executive and Director
Where does Ken Riker currently live?
Everett, Washington is the place where Ken Riker lives
Does Ken Riker have the email address?
fi**@comcast.net is Ken's email address.
How many companies did Ken Riker work at?
The professional worked at five jobs.
What education does Ken Riker have?
Ken studied at the University of Washington from 1982 to 1995.
What is the industry that Ken Riker worked in?
This professional works in Biotechnology industry.
What are special skills of Ken Riker?
Ken has such skills as Biotechnology, Gmp, Biopharmaceuticals, Pharmaceutical Industry, Fda, Quality Control, Validation, Capa, Change Control, and 21 Cfr Part 11.